Global Drugs for Osteoarthritis Pain Sales Market Report 2017

Choose Licence

 

Notes: Sales, means the sales volume of Drugs for Osteoarthritis Pain Revenue, means the sales value of Drugs for Osteoarthritis Pain This report studies sales (consumption) of Drugs for Osteoarthritis Pain in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Abbott Laboratories Johnson & Johnson Novartis International Pfizer AbbVie Abiogen Pharma Afferent Pharmaceuticals Astellas Pharma BioDelivery Sciences International CrystalGenomics Cytori Therapeutics Daiichi Sankyo Eli Lilly Endo Pharmaceuticals Holdings Horizon Pharma ICeutica Iroko Pharmaceuticals Merck Nuvo Research Regeneron Pharmaceuticals Sanofi SantoSolve Techfields Pharma Winston Pharmaceuticals Yooyoung Pharmaceutical Zynerba Pharmaceuticals Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Drugs for Osteoarthritis Pain in these regions, from 2011 to 2021 (forecast), like United States China Europe Japan Southeast Asia India Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into OTC Prescription Split by applications, this report focuses on sales, market share and growth rate of Drugs for Osteoarthritis Pain in each application, can be divided into Hospital Clinics Household

 

Table of Contents Global Drugs for Osteoarthritis Pain Sales Market Report 2017 1 Drugs for Osteoarthritis Pain Overview 1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain 1.2 Classification of Drugs for Osteoarthritis Pain 1.2.1 OTC 1.2.2 Prescription 1.3 Application of Drugs for Osteoarthritis Pain 1.3.1 Hospital 1.3.2 Clinics 1.3.3 Household 1.4 Drugs for Osteoarthritis Pain Market by Regions 1.4.1 United States Status and Prospect (2011-2021) 1.4.2 China Status and Prospect (2011-2021) 1.4.3 Europe Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.4.5 Southeast Asia Status and Prospect (2011-2021) 1.4.6 India Status and Prospect (2011-2021) 1.5 Global Market Size (Value and Volume) of Drugs for Osteoarthritis Pain (2011-2021) 1.5.1 Global Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021) 1.5.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021) 2 Global Drugs for Osteoarthritis Pain Competition by Manufacturers, Type and Application 2.1 Global Drugs for Osteoarthritis Pain Market Competition by Manufacturers 2.1.1 Global Drugs for Osteoarthritis Pain Sales and Market Share of Key Manufacturers (2011-2016) 2.1.2 Global Drugs for Osteoarthritis Pain Revenue and Share by Manufacturers (2011-2016) 2.2 Global Drugs for Osteoarthritis Pain (Volume and Value) by Type 2.2.1 Global Drugs for Osteoarthritis Pain Sales and Market Share by Type (2011-2016) 2.2.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016) 2.3 Global Drugs for Osteoarthritis Pain (Volume and Value) by Regions 2.3.1 Global Drugs for Osteoarthritis Pain Sales and Market Share by Regions (2011-2016) 2.3.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Regions (2011-2016) 2.4 Global Drugs for Osteoarthritis Pain (Volume) by Application 3 United States Drugs for Osteoarthritis Pain (Volume, Value and Sales Price) 3.1 United States Drugs for Osteoarthritis Pain Sales and Value (2011-2016) 3.1.1 United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) 3.1.2 United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) 3.1.3 United States Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) 3.2 United States Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers 3.3 United States Drugs for Osteoarthritis Pain Sales and Market Share by Type 3.4 United States Drugs for Osteoarthritis Pain Sales and Market Share by Application 4 China Drugs for Osteoarthritis Pain (Volume, Value and Sales Price) 4.1 China Drugs for Osteoarthritis Pain Sales and Value (2011-2016) 4.1.1 China Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) 4.1.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) 4.1.3 China Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) 4.2 China Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers 4.3 China Drugs for Osteoarthritis Pain Sales and Market Share by Type 4.4 China Drugs for Osteoarthritis Pain Sales and Market Share by Application 5 Europe Drugs for Osteoarthritis Pain (Volume, Value and Sales Price) 5.1 Europe Drugs for Osteoarthritis Pain Sales and Value (2011-2016) 5.1.1 Europe Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) 5.1.2 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) 5.1.3 Europe Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) 5.2 Europe Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers 5.3 Europe Drugs for Osteoarthritis Pain Sales and Market Share by Type 5.4 Europe Drugs for Osteoarthritis Pain Sales and Market Share by Application 6 Japan Drugs for Osteoarthritis Pain (Volume, Value and Sales Price) 6.1 Japan Drugs for Osteoarthritis Pain Sales and Value (2011-2016) 6.1.1 Japan Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) 6.1.2 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) 6.1.3 Japan Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) 6.2 Japan Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers 6.3 Japan Drugs for Osteoarthritis Pain Sales and Market Share by Type 6.4 Japan Drugs for Osteoarthritis Pain Sales and Market Share by Application 7 Southeast Asia Drugs for Osteoarthritis Pain (Volume, Value and Sales Price) 7.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Value (2011-2016) 7.1.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) 7.1.2 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) 7.1.3 Southeast Asia Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) 7.2 Southeast Asia Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers 7.3 Southeast Asia Drugs for Osteoarthritis Pain Sales and Market Share by Type 7.4 Southeast Asia Drugs for Osteoarthritis Pain Sales and Market Share by Application 8 India Drugs for Osteoarthritis Pain (Volume, Value and Sales Price) 8.1 India Drugs for Osteoarthritis Pain Sales and Value (2011-2016) 8.1.1 India Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) 8.1.2 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) 8.1.3 India Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) 8.2 India Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers 8.3 India Drugs for Osteoarthritis Pain Sales and Market Share by Type 8.4 India Drugs for Osteoarthritis Pain Sales and Market Share by Application 9 Global Drugs for Osteoarthritis Pain Manufacturers Analysis 9.1 Abbott Laboratories 9.1.1 Company Basic Information, Manufacturing Base and Competitors 9.1.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.1.2.1 OTC 9.1.2.2 Prescription 9.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.1.4 Main Business/Business Overview 9.2 Johnson & Johnson 9.2.1 Company Basic Information, Manufacturing Base and Competitors 9.2.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.2.2.1 OTC 9.2.2.2 Prescription 9.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.2.4 Main Business/Business Overview 9.3 Novartis International 9.3.1 Company Basic Information, Manufacturing Base and Competitors 9.3.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.3.2.1 OTC 9.3.2.2 Prescription 9.3.3 Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.3.4 Main Business/Business Overview 9.4 Pfizer 9.4.1 Company Basic Information, Manufacturing Base and Competitors 9.4.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.4.2.1 OTC 9.4.2.2 Prescription 9.4.3 Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.4.4 Main Business/Business Overview 9.5 AbbVie 9.5.1 Company Basic Information, Manufacturing Base and Competitors 9.5.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.5.2.1 OTC 9.5.2.2 Prescription 9.5.3 AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.5.4 Main Business/Business Overview 9.6 Abiogen Pharma 9.6.1 Company Basic Information, Manufacturing Base and Competitors 9.6.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.6.2.1 OTC 9.6.2.2 Prescription 9.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.6.4 Main Business/Business Overview 9.7 Afferent Pharmaceuticals 9.7.1 Company Basic Information, Manufacturing Base and Competitors 9.7.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.7.2.1 OTC 9.7.2.2 Prescription 9.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.7.4 Main Business/Business Overview 9.8 Astellas Pharma 9.8.1 Company Basic Information, Manufacturing Base and Competitors 9.8.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.8.2.1 OTC 9.8.2.2 Prescription 9.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.8.4 Main Business/Business Overview 9.9 BioDelivery Sciences International 9.9.1 Company Basic Information, Manufacturing Base and Competitors 9.9.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.9.2.1 OTC 9.9.2.2 Prescription 9.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.9.4 Main Business/Business Overview 9.10 CrystalGenomics 9.10.1 Company Basic Information, Manufacturing Base and Competitors 9.10.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification 9.10.2.1 OTC 9.10.2.2 Prescription 9.10.3 CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) 9.10.4 Main Business/Business Overview 9.11 Cytori Therapeutics 9.12 Daiichi Sankyo 9.13 Eli Lilly 9.14 Endo Pharmaceuticals Holdings 9.15 Horizon Pharma 9.16 ICeutica 9.17 Iroko Pharmaceuticals 9.18 Merck 9.19 Nuvo Research 9.20 Regeneron Pharmaceuticals 9.21 Sanofi 9.22 SantoSolve 9.23 Techfields Pharma 9.24 Winston Pharmaceuticals 9.25 Yooyoung Pharmaceutical 9.26 Zynerba Pharmaceuticals 10 Drugs for Osteoarthritis Pain Maufacturing Cost Analysis 10.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis 10.1.1 Key Raw Materials 10.1.2 Price Trend of Key Raw Materials 10.1.3 Key Suppliers of Raw Materials 10.1.4 Market Concentration Rate of Raw Materials 10.2 Proportion of Manufacturing Cost Structure 10.2.1 Raw Materials 10.2.2 Labor Cost 10.2.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain 10.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 11.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis 11.2 Upstream Raw Materials Sourcing 11.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015 11.4 Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Marketing Channel 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes Threat 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs/Customer Preference Change 13.3 Economic/Political Environmental Change 14 Global Drugs for Osteoarthritis Pain Market Forecast (2016-2021) 14.1 Global Drugs for Osteoarthritis Pain Sales, Revenue and Price Forecast (2016-2021) 14.1.1 Global Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021) 14.1.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021) 14.1.3 Global Drugs for Osteoarthritis Pain Price and Trend Forecast (2016-2021) 14.2 Global Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast by Regions (2016-2021) 14.2.1 United States Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021) 14.2.2 China Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021) 14.2.3 Europe Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021) 14.2.4 Japan Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021) 14.2.5 Southeast Asia Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021) 14.2.6 India Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021) 14.3 Global Drugs for Osteoarthritis Pain Sales, Revenue and Price Forecast by Type (2016-2021) 14.4 Global Drugs for Osteoarthritis Pain Sales Forecast by Application (2016-2021) 15 Research Findings and Conclusion 16 Appendix Methodology Analyst Introduction Data Source

List of Tables and Figures Figure Picture of Drugs for Osteoarthritis Pain Table Classification of Drugs for Osteoarthritis Pain Figure Global Sales Market Share of Drugs for Osteoarthritis Pain by Type in 2015 Figure OTC Picture Figure Prescription Picture Table Applications of Drugs for Osteoarthritis Pain Figure Global Sales Market Share of Drugs for Osteoarthritis Pain by Application in 2015 Figure Hospital Examples Figure Clinics Examples Figure Household Examples Figure United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021) Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021) Figure Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021) Figure Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021) Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021) Figure India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021) Figure Global Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021) Figure Global Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021) Table Global Drugs for Osteoarthritis Pain Sales of Key Manufacturers (2011-2016) Table Global Drugs for Osteoarthritis Pain Sales Share by Manufacturers (2011-2016) Figure 2015 Drugs for Osteoarthritis Pain Sales Share by Manufacturers Figure 2016 Drugs for Osteoarthritis Pain Sales Share by Manufacturers Table Global Drugs for Osteoarthritis Pain Revenue by Manufacturers (2011-2016) Table Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers (2011-2016) Table 2015 Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers Table 2016 Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers Table Global Drugs for Osteoarthritis Pain Sales and Market Share by Type (2011-2016) Table Global Drugs for Osteoarthritis Pain Sales Share by Type (2011-2016) Figure Sales Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016) Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2011-2016) Table Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016) Table Global Drugs for Osteoarthritis Pain Revenue Share by Type (2011-2016) Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016) Figure Global Drugs for Osteoarthritis Pain Revenue Growth Rate by Type (2011-2016) Table Global Drugs for Osteoarthritis Pain Sales and Market Share by Regions (2011-2016) Table Global Drugs for Osteoarthritis Pain Sales Share by Regions (2011-2016) Figure Sales Market Share of Drugs for Osteoarthritis Pain by Regions (2011-2016) Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Regions (2011-2016) Table Global Drugs for Osteoarthritis Pain Revenue and Market Share by Regions (2011-2016) Table Global Drugs for Osteoarthritis Pain Revenue Share by Regions (2011-2016) Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Regions (2011-2016) Figure Global Drugs for Osteoarthritis Pain Revenue Growth Rate by Regions (2011-2016) Table Global Drugs for Osteoarthritis Pain Sales and Market Share by Application (2011-2016) Table Global Drugs for Osteoarthritis Pain Sales Share by Application (2011-2016) Figure Sales Market Share of Drugs for Osteoarthritis Pain by Application (2011-2016) Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Application (2011-2016) Figure United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) Figure United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) Figure United States Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) Table United States Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016) Table United States Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016) Table United States Drugs for Osteoarthritis Pain Sales by Type (2011-2016) Table United States Drugs for Osteoarthritis Pain Market Share by Type (2011-2016) Table United States Drugs for Osteoarthritis Pain Sales by Application (2011-2016) Table United States Drugs for Osteoarthritis Pain Market Share by Application (2011-2016) Figure China Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) Figure China Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) Table China Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016) Table China Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016) Table China Drugs for Osteoarthritis Pain Sales by Type (2011-2016) Table China Drugs for Osteoarthritis Pain Market Share by Type (2011-2016) Table China Drugs for Osteoarthritis Pain Sales by Application (2011-2016) Table China Drugs for Osteoarthritis Pain Market Share by Application (2011-2016) Figure Europe Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) Figure Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) Figure Europe Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) Table Europe Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016) Table Europe Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016) Table Europe Drugs for Osteoarthritis Pain Sales by Type (2011-2016) Table Europe Drugs for Osteoarthritis Pain Market Share by Type (2011-2016) Table Europe Drugs for Osteoarthritis Pain Sales by Application (2011-2016) Table Europe Drugs for Osteoarthritis Pain Market Share by Application (2011-2016) Figure Japan Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) Figure Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) Figure Japan Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) Table Japan Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016) Table Japan Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016) Table Japan Drugs for Osteoarthritis Pain Sales by Type (2011-2016) Table Japan Drugs for Osteoarthritis Pain Market Share by Type (2011-2016) Table Japan Drugs for Osteoarthritis Pain Sales by Application (2011-2016) Table Japan Drugs for Osteoarthritis Pain Market Share by Application (2011-2016) Figure Southeast Asia Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) Table Southeast Asia Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016) Table Southeast Asia Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016) Table Southeast Asia Drugs for Osteoarthritis Pain Sales by Type (2011-2016) Table Southeast Asia Drugs for Osteoarthritis Pain Market Share by Type (2011-2016) Table Southeast Asia Drugs for Osteoarthritis Pain Sales by Application (2011-2016) Table Southeast Asia Drugs for Osteoarthritis Pain Market Share by Application (2011-2016) Figure India Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016) Figure India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016) Figure India Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016) Table India Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016) Table India Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016) Table India Drugs for Osteoarthritis Pain Sales by Type (2011-2016) Table India Drugs for Osteoarthritis Pain Market Share by Type (2011-2016) Table India Drugs for Osteoarthritis Pain Sales by Application (2011-2016) Table India Drugs for Osteoarthritis Pain Market Share by Application (2011-2016) Table Abbott Laboratories Basic Information List Table Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure Abbott Laboratories Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table Johnson & Johnson Basic Information List Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure Johnson & Johnson Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table Novartis International Basic Information List Table Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure Novartis International Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table Pfizer Basic Information List Table Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure Pfizer Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table AbbVie Basic Information List Table AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure AbbVie Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table Abiogen Pharma Basic Information List Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure Abiogen Pharma Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table Afferent Pharmaceuticals Basic Information List Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table Astellas Pharma Basic Information List Table Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure Astellas Pharma Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table BioDelivery Sciences International Basic Information List Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table CrystalGenomics Basic Information List Table CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016) Figure CrystalGenomics Drugs for Osteoarthritis Pain Global Market Share (2011-2016) Table Cytori Therapeutics Basic Information List Table Daiichi Sankyo Basic Information List Table Eli Lilly Basic Information List Table Endo Pharmaceuticals Holdings Basic Information List Table Horizon Pharma Basic Information List Table ICeutica Basic Information List Table Iroko Pharmaceuticals Basic Information List Table Merck Basic Information List Table Nuvo Research Basic Information List Table Regeneron Pharmaceuticals Basic Information List Table Sanofi Basic Information List Table SantoSolve Basic Information List Table Techfields Pharma Basic Information List Table Winston Pharmaceuticals Basic Information List Table Yooyoung Pharmaceutical Basic Information List Table Zynerba Pharmaceuticals Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015 Table Major Buyers of Drugs for Osteoarthritis Pain Table Distributors/Traders List Figure Global Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021) Figure Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021) Table Global Drugs for Osteoarthritis Pain Sales Forecast by Regions (2016-2021) Table Global Drugs for Osteoarthritis Pain Sales Forecast by Type (2016-2021) Table Global Drugs for Osteoarthritis Pain Sales Forecast by Application (2016-2021)

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Water-Hammer Arrestor Market Professional Survey Report 2017

This report studies Water-Hammer Arrestor in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 202...

Global Viral Molecular Diagnostics Market Professional Survey Report 2017

This report studies Viral Molecular Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast ...

Global Ultraviolet Tanning Bed Market Professional Survey Report 2017

This report studies Ultraviolet Tanning Bed in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2...

Global True Redox Flow Battery Market Professional Survey Report 2017

This report studies True Redox Flow Battery in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2...

Global The Fifth Generation Building Membrane Market Professional Survey Report 2017

This report studies The Fifth Generation Building Membrane in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, an...

New Pharmaceuticals and Healthcare Reports